Average Co-Inventor Count = 3.12
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (20 from 2,285 patents)
2. Allergan Sales, Inc. (1 from 228 patents)
21 patents:
1. 10221192 - Compounds as tyrosine kinase modulators
2. 9758509 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
3. 9725433 - Compounds as tyrosine kinase modulators
4. 9657005 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
5. 9475801 - Compounds as tyrosine kinase modulators
6. 9340555 - Compounds as tyrosine kinase modulators
7. 9328103 - Compounds as tyrosine kinase modulators
8. 8906944 - Compounds as tyrosine kinase modulators
9. 8877923 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
10. 8865682 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
11. 8809534 - Compounds as tyrosine kinase modulators
12. 8614234 - Compounds as tyrosine kinase modulators
13. 8455535 - Heteroaryl dihydroindolones as kinase inhibitors
14. 8455656 - Kinase inhibitors
15. 8367664 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors